COMMITTEE ON MILITARY AFFAIRS & PUBLIC SAFETY
HOUSE OF REPRESENTATIVES AMENDMENTS TO H.B. 2274
(Reference to printed bill)
Page 1, after line 19, insert:
"Sec. 2. Conditional enactment; notice
A. This act does not become effective unless on or before January 1, 2026 a 3, 4-methylenedioxymethamphetamine investigational product is newly approved as a prescription medication pursuant to 21 United States Code section 355 and is controlled under a federal interim final rule issued pursuant to 21 United States Code section 811(j) and published in the Federal Register.
B. The executive director of the Arizona state board of pharmacy shall notify in writing the director of the Arizona legislative council on or before February 1, 2026 either:
1. Of the date on which the condition was met.
2. That the condition was not met."
Amend title to conform